Selling clinical chemistry and haematology reagents and analysers in Egypt: a distributor and importer for manufacturers
Last verified:
Clinical chemistry, haematology and coagulation reagents (HS 3822.19) and blood-grouping reagents (3822.13) pay 5% import duty in Egypt, 0% for EU, UK, EFTA and Turkish goods with proof of origin, and medical-use analysers (9027.89.00.10) pay 0% (Egyptian Customs tariff). They need an EDA IVD marketing licence valid 5 years, and the first three batches imported after the licence are analysed by EDA and released only after the result (EDA IVD rules). Egypt imported US$87.67 million of HS 3822.19 reagents and kits in 2025 — a line shared with immunoassay, PCR and rapid tests — with China the largest origin, plus US$43.89 million of blood-grouping reagents, led by the USA (UN Comtrade).
Buying in Egypt?
Hospitals, labs and clinics in Egypt can order from the UltraTeb online shop.
Go to the UltraTeb shopA manufacturer or exporter?
Supply your products to Egypt — and from there to Africa and the Middle East — with UltraTeb Market Access.
Apply — 2 minutesUltraTeb Market Access is a zero-upfront-fee route into Egypt's medical market: UltraTeb registers, imports, markets, stores and sells your product, shares the risk, and pays you when it sells.
Buying lab and diagnostic products in Egypt? Laboratories and hospitals can see UltraTeb's lab and diagnostics range and ask for a quote on UltraTeb's B2B web shop: lab and diagnostics products on shop.ultrateb.com. The rest of this page is for manufacturers who want to sell in Egypt.
What are the key facts for clinical chemistry and haematology in Egypt?
| Fact | Value | Source | As of |
|---|---|---|---|
| HS codes | 3822.19 other diagnostic reagents and kits (chemistry, haematology and coagulation reagents, calibrators and controls); 3822.13 blood-grouping reagents; 3822.90 certified reference materials; 9027.89 analysers (national line 9027.89.00.10, medical use); 9027.30 spectrophotometers (9027.30.00.10, medical use); 9027.90 parts and accessories | customs.gov.eg | |
| Import duty (MFN) | 5% on reagents (3822.13, 3822.19, 3822.90); 0% on medical-use analysers and spectrophotometers (9027.89.00.10, 9027.30) and their parts (9027.90.10). Analysers also need a Weights & Measures release approval (tariff instruction ق4510) | customs.gov.eg | |
| Import duty with a trade agreement | 0% for EU, EFTA, UK and Turkish origin and under MERCOSUR (List D), with proof of origin. AfCFTA: 100% (group A) or 60% (group B) reduction. Serbia: 20% reduction on 3822.19 and 3822.90, 50% on blood-grouping reagents. Analysers are already 0%. Goods from China, India, Korea, Japan and the USA pay the MFN rate | customs.gov.eg | |
| Import VAT | 14% shown on the official tariff for reagents and kits, probably not covered by Law 149 of 2026's 5% rate, which speaks of 'devices'. Analysers: 14% shown, possibly 5% when a lab buys them to provide a service. The rate is not settled, so we confirm your product's rate before pricing | mof.gov.eg | |
| EDA route | IVD registration with EDA's Central Administration of Medical Devices, giving a 5-year marketing licence (re-register in its last 6 months). Imports run on an annual import approval per foreign factory, with no quantities, plus a precautionary release per invoice. The outer pack must show the legal manufacturer, country of origin, expiry, batch and Egyptian registration number, and EDA's vigilance QR code | edaegypt.gov.eg | |
| Selling while the licence is pending | Items never circulated in Egypt before may be sold for 6 months from the first import approval while the licence file is pending | edaegypt.gov.eg | |
| Typical class | General IVD for clinical-chemistry and haematology tests and analysers (EDA's own examples); ABO blood-grouping reagents are Annex II List A (high risk); blood-glucose self-tests are List B. EDA's 04/2021 guideline still uses the IVD Directive categories | edaegypt.gov.eg | |
| Trap: the first three batches | The first three batches imported after the marketing licence are analysed by EDA's laboratories and each is released only after the result, so stock and shelf life must be planned around the hold | edaegypt.gov.eg | |
| Trap: analysers need a maintenance-centre licence | The importer's EDA register must state a valid maintenance-centre licence, and analysers must be new; used or refurbished instruments for reagent-rental placements need an EDA referral | edaegypt.gov.eg | |
| Trap: reagent-rental analysers | Analysers placed in customer labs on reagent-rental deals and temporarily released stay foreign-owned equipment in use in Egypt: 2% of the suspended duty per month, at most 20% a year (Customs Law 207/2020, Art. 34). Duty on 9027.89.00.10 is 0%, so this mainly matters for VAT treatment and other lines — our reading, to be confirmed per deal | kadmar.com | 2020 |
| Trap: no Free Sale Certificate, no licence | The IVD must already be circulated in its country of origin or an EDA reference country, and certificates from non-reference countries must be legalised | edaegypt.gov.eg | |
| Local manufacturing | Yes. An Egyptian IVD maker (ISO 13485, CE) makes clinical-chemistry, haematology, haemostasis and blood-grouping reagents, calibrators and controls, and semi- and fully-automated chemistry analysers. It reports supplying 30% of the government's manual chemistry reagents (2017) and 25% of the country's clinical-chemistry needs — self-reported figures | medica.de | 2025 |
| Public-tender preference | An Egyptian product with more than 40% local content is treated as the lowest bid if it is within 15% of the lowest foreign bid, so imported chemistry and haematology reagents compete with that preference in UPA tenders | trade.gov | |
| Localisation push: blood grouping | A French blood-grouping reagent maker discussed local production in Egypt with technology transfer (June 2026); no production start has been confirmed | see.news | |
| Egypt reagent imports, 2025 (HS 3822, all diagnostic and lab reagents) | US$182.3 million: USA 42.0M, Germany 40.9M, China 24.8M, Korea 10.2M, France 9.4M, UK 8.5M, India 6.5M, Ireland 5.3M. 2024: US$173.8 million (USA 44.8M, Germany 41.8M, China 18.4M, UK 9.4M). The heading also covers non-diagnostic lab reagents | comtradeapi.un.org | 2025 |
| Egypt imports of other reagents and kits, 2025 (HS 3822.19) | US$87.67 million: China 17.89M, Germany 15.55M, USA 14.63M, Korea 7.47M, France 6.24M, Finland 4.07M, Canada 2.70M. The line holds chemistry, immunoassay, PCR and rapid-test kits together | comtradeapi.un.org | 2025 |
| Egypt blood-grouping reagent imports, 2025 (HS 3822.13) | US$43.89 million: USA 13.12M, Germany 6.49M, UK 4.53M, China 3.58M, Korea 2.39M, India 2.36M, Japan 1.83M. Its size relative to 3822.19 suggests other reagents may be declared on this line — not verified | comtradeapi.un.org | 2025 |
| Egypt analyser imports, 2025 (HS 9027) | US$75.8 million: USA 15.0M, China 11.7M, Germany 11.5M, Japan 8.5M, UK 4.5M, Singapore 3.8M, Italy 3.5M, Switzerland 2.4M. Includes industrial and research analysers | comtradeapi.un.org | 2025 |
| Egypt analyser and spectrophotometer imports, 2024 (HS 9027.80, 9027.30) | HS 9027.80 (now 9027.81 + 9027.89): US$14.35 million — China 2.49M, USA 2.28M, Japan 1.62M, Mexico 1.41M, Sweden 1.02M, Switzerland 0.89M. HS 9027.30 spectrophotometers: US$9.94 million — USA 2.04M, Germany 2.00M, Singapore 1.35M | wits.worldbank.org | 2024 |
| Search demand we measured | 'laboratory reagents suppliers' 210 searches a month and 'ivd distributor' 70 searches a month, worldwide (Google Keyword Planner, UltraTeb measurement). Generic IVD terms shared by all lab categories, not specific to chemistry or haematology | ads.google.com |
Duty and VAT from Egypt's official tariff (Egyptian Customs Authority). EDA rules from its IVD guideline GL.CAMD.001 (issued 04/2021, still using the IVD Directive categories; a newer version may exist) and its lab and diagnostic equipment import guideline GL.CAMD.004. Trade values are Egypt-reported CIF imports for whole HS lines (UN Comtrade, World Bank WITS), including non-diagnostic reagents and non-medical analysers. Last verified 2026-09-25.
Last verified:
What does it take to sell clinical chemistry and haematology products in Egypt?
-
Have the certificates ready
CE marking under the IVD Directive or IVDR (self-declared for general IVDs, a notified-body certificate for blood grouping and other List A products), ISO 13485:2016, a Declaration of Conformity stating the IVD Directive and class, and a Free Sale Certificate. On the US route, an FDA Certificate to Foreign Government and a 21 CFR 862/864 classification letter.
-
Show it is already sold, and legalise if needed
The IVD must already be circulated in its country of origin or an EDA reference country. Certificates from non-reference countries must be legalised.
-
Get the EDA IVD marketing licence
Your Egyptian distributor files with EDA's Central Administration of Medical Devices for a 5-year licence, renewed in its last 6 months. Items never sold in Egypt before may be sold for 6 months from the first import approval while the file is pending. For analysers, the importer's register must state a valid maintenance-centre licence.
-
Plan stock around the first three batches
EDA's laboratories analyse the first three batches imported after the licence and release each one only after the result, so shipment size and shelf life must allow for the hold.
-
Import, clear customs and pay duty and VAT
An annual import approval per foreign factory plus a precautionary release per invoice. Reagents pay 5% duty (0% with an EU, UK, EFTA or Turkish proof of origin), analysers 0% with a Weights & Measures release approval, then import VAT.
-
Sell to the right buyers
Private lab chains and private hospital laboratories, public hospitals, blood banks and screening programmes through UPA and public tenders where the product can compete, and Universal Health Insurance hospitals.
Who buys clinical chemistry and haematology products in Egypt?
- Private lab chains. Private testing is concentrated: the largest group holds about 45% of private diagnostics through 300+ branches, and several other chains follow.
- Hospital laboratories — public hospitals through UPA tripartite contracts, and private hospital groups.
- Blood banks and national screening programmes, through public tenders.
- Universal Health Insurance hospitals — phase 1 covers 6 governorates and phase 2 about 70 hospitals.
Do imported chemistry reagents compete with Egyptian-made ones?
Yes, in routine chemistry. An Egyptian IVD maker produces chemistry, haematology, haemostasis and blood-grouping reagents and chemistry analysers, and reports covering 25% of the country's clinical-chemistry needs. In public tenders a qualifying Egyptian product within 15% of the lowest foreign bid is treated as the lowest (US State Department), and local production of blood-grouping reagents is under discussion.
So we look first at what local lines cover less: closed-system analyser and reagent packages and specialised haematology and coagulation are where we start, and the free market study checks your product against real demand and local prices before anything ships.
How does UltraTeb Market Access sell your clinical chemistry and haematology products?
-
Free market study and pricing
We check where your reagents or analysers fit against local supply and price them for private lab chains and, where they can compete, UPA tenders.
-
EDA IVD registration, end to end
We tell you which certificates need legalising, file the IVD marketing licence, and plan the first-three-batch testing so stock does not expire waiting for release.
-
Import, customs, duty and VAT
The annual import approval per factory, precautionary releases, Weights & Measures approval for analysers, clearance, and the duty and VAT paid by us. We tell you which origin document gets EU, UK, EFTA or Turkish reagents in at 0%.
-
Warehousing by lot and expiry
Stored and picked first-expiry-first-out, with your stock visible to you at all times.
-
Marketing and distribution
Arabic and English product pages on shop.ultrateb.com and campaigns once EDA advertising approval is in place, our sales team calling on private lab chains and hospital laboratories, and bids in UPA tenders where your product can compete.
“A lab reorders the reagents it trusts. We do the registration work that earns that trust at our own cost, and we are paid only when your reagents sell.” — Mohamed Dabees, founder, UltraTeb
Frequently asked questions
What import duty do clinical chemistry and haematology products pay in Egypt?
Reagents (3822.13, 3822.19, 3822.90) pay 5% and medical-use analysers (9027.89.00.10) 0%. EU, UK, EFTA and Turkish reagents enter at 0% with valid proof of origin; goods from China, India, Korea, Japan and the USA pay the MFN rate (Egyptian Customs tariff).
Is the VAT on diagnostic reagents 14% or 5%?
The official tariff shows 14%. Law 149 of 2026 added a 5% rate for devices used to provide a service, which probably does not cover reagents and may cover analysers bought by a lab. We confirm your product's rate before we price it, because tender prices include VAT.
What happens to the first shipments after the EDA licence?
The first three batches imported after the marketing licence are analysed by EDA's laboratories, and each is released only after the result (EDA IVD rules). We plan shipment sizes and shelf life around that hold.
Can I sell reagents while the EDA licence is pending?
Only items never circulated in Egypt before, and only for 6 months from the first import approval while the licence file is pending. The licence itself is valid 5 years. See IVD registration in Egypt.
Do my certificates need to be legalised?
Yes, if they come from a country that is not an EDA reference country. The IVD must also already be circulated in its country of origin or a reference country, shown by a Free Sale Certificate. See EDA reference countries.
Are clinical chemistry reagents made in Egypt?
Yes. An Egyptian IVD maker produces chemistry, haematology, haemostasis and blood-grouping reagents and chemistry analysers, and reports covering 25% of the country's clinical-chemistry needs. In UPA tenders a qualifying Egyptian product within 15% of the lowest foreign bid is treated as the lowest, so the free market study checks where your product has room.
Who pays for registration, duty and VAT with UltraTeb Market Access?
We do. Registration, import, duty and VAT, storage and marketing are funded by UltraTeb, and you are paid when your goods sell.
Where can buyers in Egypt order lab and diagnostic products?
On UltraTeb's B2B web shop: lab and diagnostics products on shop.ultrateb.com.
Sell your clinical chemistry and haematology products in Egypt — with zero upfront fees.
Send us your product list and certificates. We check demand, local competition and the EDA IVD route in a free market study, then register, import, store, market and sell. You're paid when we sell.